Intelligent Bio Solutions Statistics
Total Valuation
INBS has a market cap or net worth of $5.99 million. The enterprise value is $217,025.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
INBS has 4.25 million shares outstanding. The number of shares has increased by 1,802.54% in one year.
| Shares Outstanding | 4.25M |
| Shares Change (YoY) | +1,802.54% |
| Shares Change (QoQ) | +46.20% |
| Owned by Insiders (%) | 2.23% |
| Owned by Institutions (%) | 12.43% |
| Float | 4.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| Forward PS | 0.50 |
| PB Ratio | 0.58 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.57 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -61.52 |
Financial Efficiency
Return on equity (ROE) is -171.71% and return on invested capital (ROIC) is -91.31%.
| Return on Equity (ROE) | -171.71% |
| Return on Assets (ROA) | -53.26% |
| Return on Capital (ROIC) | -91.31% |
| Revenue Per Employee | $62,236 |
| Profits Per Employee | -$203,135 |
| Employee Count | 50 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 1.92 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.16% in the last 52 weeks. The beta is 4.72, so INBS's price volatility has been higher than the market average.
| Beta (5Y) | 4.72 |
| 52-Week Price Change | -51.16% |
| 50-Day Moving Average | 1.62 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 43.20 |
| Average Volume (20 Days) | 74,659 |
Short Selling Information
The latest short interest is 369,426, so 8.69% of the outstanding shares have been sold short.
| Short Interest | 369,426 |
| Short Previous Month | 297,280 |
| Short % of Shares Out | 8.69% |
| Short % of Float | 8.92% |
| Short Ratio (days to cover) | 1.25 |
Income Statement
In the last 12 months, INBS had revenue of $3.11 million and -$10.16 million in losses. Loss per share was -$6.38.
| Revenue | 3.11M |
| Gross Profit | 1.43M |
| Operating Income | -10.28M |
| Pretax Income | -10.03M |
| Net Income | -10.16M |
| EBITDA | -9.31M |
| EBIT | -10.28M |
| Loss Per Share | -$6.38 |
Full Income StatementBalance Sheet
The company has $6.42 million in cash and $871,440 in debt, giving a net cash position of $5.54 million or $1.30 per share.
| Cash & Cash Equivalents | 6.42M |
| Total Debt | 871,440 |
| Net Cash | 5.54M |
| Net Cash Per Share | $1.30 |
| Equity (Book Value) | 8.18M |
| Book Value Per Share | 2.41 |
| Working Capital | 3.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.57 million and capital expenditures -$221,426, giving a free cash flow of -$9.79 million.
| Operating Cash Flow | -9.57M |
| Capital Expenditures | -221,426 |
| Free Cash Flow | -9.79M |
| FCF Per Share | -$2.30 |
Full Cash Flow StatementMargins
| Gross Margin | 45.81% |
| Operating Margin | -330.46% |
| Pretax Margin | -327.50% |
| Profit Margin | n/a |
| EBITDA Margin | -299.15% |
| EBIT Margin | n/a |
| FCF Margin | -241.86% |